Hydroxocobalamin Patent Expiration
Hydroxocobalamin is Used for the treatment of cyanide poisoning. It was first introduced by Btg International Inc
Hydroxocobalamin Patents
Given below is the list of patents protecting Hydroxocobalamin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cyanokit | US5834448 | Dosage form of hydroxocobalamin and its use in cyanide poisoning |
Nov 14, 2016
(Expired) | Btg Intl |
Hydroxocobalamin's Family Patents
Explore Our Curated Drug Screens
Hydroxocobalamin Generic API Manufacturers
Several generic applications have been filed for Hydroxocobalamin. The first generic version for Hydroxocobalamin was by Bel Mar Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Abraxis Pharmaceutical Products and was approved on Approved Prior to Jan 1, 1982.
Given below is the list of companies who have filed for Hydroxocobalamin generic, along with the locations of their manufacturing plants worldwide.
1. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 1 generic for Hydroxocobalamin. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
2. ACTAVIS
Actavis Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Hydroxocobalamin. Given below are the details of the strengths of this generic introduced by Actavis.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML
(reference standard) | injectable | Prescription | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Actavis's manufacturing plants are situated in 4 countries - Romania, United States, Italy, India. Given below are the details of these plant locations as well as the firm names of Actavis as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Romania |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||
| Italy |
| |||||||||||||||||||||||
| India |
| |||||||||||||||||||||||
3. BEL MAR
Bel Mar Laboratories Inc has filed for 1 generic for Hydroxocobalamin. This 1mg/ml version comes by the name HYDROXOMIN. Given below are the details of the strengths of this generic introduced by Bel Mar.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
4. MERCK
Merck And Co Inc has filed for 1 generic for Hydroxocobalamin. This 1mg/ml version comes by the name ALPHAREDISOL. Given below are the details of the strengths of this generic introduced by Merck.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Merck's manufacturing plants are situated in 9 countries - United States, France, Switzerland, Germany, Ireland, Mexico, Italy, Australia, Netherlands. Given below are the details of these plant locations as well as the firm names of Merck as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||
| France |
| |||||||||||||||||||||
| Switzerland |
| |||||||||||||||||||||
| Germany |
| |||||||||||||||||||||
| Ireland |
| |||||||||||||||||||||
| Mexico |
| |||||||||||||||||||||
| Italy |
| |||||||||||||||||||||
| Australia |
| |||||||||||||||||||||
| Netherlands |
| |||||||||||||||||||||
5. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Hydroxocobalamin. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |